SEPT8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.924800E-01
Normal-vs-Stage2
7.665600E-01
Normal-vs-Stage3
4.826200E-01
Normal-vs-Stage4
2.931400E-01
Stage1-vs-Stage2
4.642000E-01
Stage1-vs-Stage3
3.892200E-01
Stage1-vs-Stage4
7.762200E-02
Stage2-vs-Stage3
1.544840E-01
Stage2-vs-Stage4
7.911900E-02
Stage3-vs-Stage4
9.718300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.029600E-01
Normal-vs-AfricanAmerican
8.781400E-01
Normal-vs-Asian
8.733000E-01
Caucasian-vs-AfricanAmerican
9.906400E-01
Caucasian-vs-Asian
9.210600E-01
AfricanAmerican-vs-Asian
9.659400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.311400E-01
Normal-vs-Female
7.233200E-01
Male-vs-Female
6.664400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.035200E-01
Normal-vs-Age(41-60Yrs)
3.818000E-01
Normal-vs-Age(61-80Yrs)
9.566600E-01
Normal-vs-Age(81-100Yrs)
6.292200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.050800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.518400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.271400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.661900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.547940E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.556400E-01
Normal-vs-Daily Drinker
8.148200E-01
Normal-vs-Weekly Drinker
7.827400E-01
Normal-vs-Occasional Drinker
6.153200E-01
Normal-vs-Social Drinker
5.914200E-01
Non Drinker-vs-Daily Drinker
7.058400E-01
Non Drinker-vs-Weekly Drinker
5.170600E-01
Non Drinker-vs-Occasional Drinker
2.713000E-01
Non Drinker-vs-Social Drinker
2.254200E-01
Daily Drinker-vs-Weekly Drinker
3.485600E-01
Daily Drinker-vs-Occasional Drinker
1.579160E-01
Daily Drinker-vs-Social Drinker
1.422170E-01
Weekly Drinker-vs-Occasional Drinker
7.533600E-01
Weekly Drinker-vs-Social Drinker
6.350600E-01
Occasional Drinker-vs-Social Drinker
8.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.925700E-02
Normal-vs-Grade 2
2.483100E-03
Normal-vs-Grade 3
7.118900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.882920E-03
Grade 1-vs-Grade 3
1.720130E-02
Grade 1-vs-Grade 4
3.925700E-02
Grade 2-vs-Grade 3
6.786200E-01
Grade 2-vs-Grade 4
2.483100E-03
Grade 3-vs-Grade 4
7.118900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.818200E-01
Normal-vs-NonDiabetic
7.641400E-01
Diabetic-vs-NonDiabetic
3.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.607400E-01
Normal-vs-NoPancreatitis
8.120400E-01
Pancreatitis-vs-NoPancreatitis
8.752200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.259800E-01
Normal-vs-N1
7.514600E-01
N0-vs-N1
7.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.286400E-01
Normal-vs-TP53-NonMutant
9.847400E-01
TP53-Mutant-vs-TP53-NonMutant
4.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
